LANXESS successfully places EUR 500 million benchmark bond

Cologne

The specialty chemicals company LANXESS has successfully placed a 6-year-tenor euro benchmark bond with a coupon of 0.0 percent in the European capital market. LANXESS will use the funds to finance the planned acquisition of the microbial control business of US-based chemical company IFF.

The new bond is listed on the Luxembourg Stock Exchange in denominations of EUR 1,000.

“We have secured a first step of financing already quickly after the announcement of the acquisition of IFF Microbial Control and are happy about the very receptive reaction of the capital market to our offering,” said LANXESS Chief Financial Officer Michael Pontzen.

LANXESS' issuer ratings are currently Baa2 (Moody’s), BBB (Standard & Poor’s) and BBB+ (Scope). A bank consortium of active joint bookrunners comprising Citi, Société Générale and Unicredit was mandated to place the bond.

Information for editors:
All global LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com.
Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

 

MORE ABOUT THIS TOPIC

PRESS RELEASE

LANXESS: innovative solutions for water treatment at Aquatech 2025

March 13, 2025
PRESS RELEASE
Lewatit TP 108 DW and TP 108

Lewatit MDS TP 108 from LANXESS removes short-chain PFAS from water

March 10, 2025
PRESS RELEASE
Scopeblue Lewatit keyvisual - employee with Lewatit in test tube on which a plant is growing

Refining high-purity battery metals with Lewatit MK51 from LANXESS

March 06, 2025
PRESS RELEASE
Rhenomark® tire marking paints

Tire Technology Expo: LANXESS presents innovative and sustainable rubber additives

March 05, 2025
PRESS RELEASE
The new module of the LewaPlus design software from LANXESS enables the dimensioning of ion exchange systems for food applications.

LewaPlus goes online

March 05, 2025